These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37485727)

  • 101. Treatment of pediatric antimuscarinic delirium with oral rivastigmine.
    Yakey B; Vohra V; Martin A; King AM
    Oxf Med Case Reports; 2023 Sep; 2023(9):omad096. PubMed ID: 37771682
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Surgery, neuroinflammation and cognitive impairment.
    Alam A; Hana Z; Jin Z; Suen KC; Ma D
    EBioMedicine; 2018 Nov; 37():547-556. PubMed ID: 30348620
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Letter in Response to Oral and Transdermal Rivastigmine for the Treatment of Anticholinergic Delirium: A Case Report.
    Jenrette JE; Lebin JA
    J Emerg Med; 2024 Feb; 66(2):262-263. PubMed ID: 38432708
    [No Abstract]   [Full Text] [Related]  

  • 104. Rivastigmine ameliorates botulinum-induced hippocampal damage and spatial memory impairment in male rats.
    Mehri K; Oskuye ZZ; Nassireslami E; Karami E; Parvizi MR
    Neurotoxicology; 2023 Sep; 98():29-38. PubMed ID: 37507053
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Comparative efficacy and safety profile of once-weekly Semaglutide versus once-daily Sitagliptin as an add-on to metformin in patients with type 2 diabetes: a systematic review and meta-analysis.
    Patel T; Nageeta F; Sohail R; Butt TS; Ganesan S; Madhurita F; Ahmed M; Zafar M; Zafar W; Zaman MU; Varrassi G; Khatri M; Kumar S
    Ann Med; 2023; 55(2):2239830. PubMed ID: 37498865
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Cholinesterase Inhibitors for Delusions and Hallucinations in Alzheimer Disease and Parkinson Disease: Questionably Significant Benefits.
    Andrade C
    J Clin Psychiatry; 2023 Jul; 84(4):. PubMed ID: 37530610
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Making Pre-screening for Alzheimer's Disease (AD) and Postoperative Delirium Among Post-Acute COVID-19 Syndrome (PACS) a National Priority: The Deep Neuro Study.
    Tarnanas I; Tsolaki M
    Adv Exp Med Biol; 2023; 1424():41-47. PubMed ID: 37486477
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Duration of Adjunctive Antidepressant Maintenance in Bipolar I Depression.
    Yatham LN; Arumugham SS; Kesavan M; Ramachandran K; Murthy NS; Saraf G; Ouyang Y; Bond DJ; Schaffer A; Ravindran A; Ravindran N; Frey BN; Daigneault A; Beaulieu S; Lam RW; Kondapuram N; Reddy MS; Bhandary RP; Ashok MV; Ha K; Ahn YM; Milev R; Wong H; Reddy YCJ;
    N Engl J Med; 2023 Aug; 389(5):430-440. PubMed ID: 37530824
    [TBL] [Abstract][Full Text] [Related]  

  • 109. NITROSOGENESIS OF SKIN CANCER: THE NITROSAMINE CONTAMINATION IN THE CALCIUM CHANNEL BLOCKERS (AMLODIPINE), BETA BLOCKERS (BISOPROLOL), SARTANS (VALSARTAN/LOSARTAN), ACE INHIBITORS (PERINDOPRIL/ENALAPRIL), TRICYCLIC ANTIDEPRESSANTS (MELITRACEN), SSRIS (PAROXETINE), SNRIS (VENLAFAXINE) AND METFORMIN: THE MOST PROBABLE EXPLANATION FOR THE RISING SKIN CANCER INCIDENCE.
    Tchernev G
    Georgian Med News; 2023 Jun; (339):24-32. PubMed ID: 37522769
    [TBL] [Abstract][Full Text] [Related]  

  • 110. A Systematic Review of Pharmacological Interventions for Apathy in Aging Neurocognitive Disorders.
    Theleritis C; Siarkos K; Politis A; Smyrnis N; Papageorgiou C; Politis AM
    Brain Sci; 2023 Jul; 13(7):. PubMed ID: 37508993
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma.
    Tan CR; Derkach A; Nemirovsky D; Ciardiello A; Diamond B; Hultcrantz M; Hassoun H; Mailankody S; Shah U; Maclachlan K; Patel D; Lahoud OB; Landau HJ; Chung DJ; Shah GL; Scordo M; Giralt SA; Lesokhin A; Usmani SZ; Landgren O; Korde N
    Blood Cancer J; 2023 Jul; 13(1):112. PubMed ID: 37491332
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Cognitive Rehabilitation for Patients with Schizophrenia: A Narrative Review of Moderating Factors, Strategies, and Outcomes.
    Skokou M; Messinis L; Nasios G; Gourzis P; Dardiotis E
    Adv Exp Med Biol; 2023; 1423():193-199. PubMed ID: 37525044
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Response trajectories during escitalopram treatment of patients with major depressive disorder.
    Nunez JJ; Liu YS; Cao B; Frey BN; Ho K; Milev R; Müller DJ; Rotzinger S; Soares CN; Taylor VH; Uher R; Kennedy SH; Lam RW
    Psychiatry Res; 2023 Sep; 327():115361. PubMed ID: 37523890
    [TBL] [Abstract][Full Text] [Related]  

  • 114. NITROSOGENESIS OF CUTANEOUS MELANOMA: SIMULTANEOUSLY DEVELOPMENT OF PRIMARY CUTANEOUS THICK MELANOMA OF THE BREAST, THIN MELANOMA/DYSPLASTIC MOLE OF THE BACK DURING PARALLEL INTAKE OF BISOPROLOL, AMLODIPINE AND VALSARTAN/ HCT: NITROSAMINE POLYCONTAMINATION IN THE MULTIMEDICATION AS THE MOST POWERFUL SKIN CANCER TRIGGER.
    Tchernev G
    Georgian Med News; 2023 Jun; (339):83-88. PubMed ID: 37522780
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Resolution of paraneoplastic alopecia areata following nivolumab in a patient with metastatic melanoma.
    Wix S; Homsi J; Gill JG
    JAAD Case Rep; 2023 Aug; 38():108-110. PubMed ID: 37521192
    [No Abstract]   [Full Text] [Related]  

  • 116. Pollen respiratory allergy: Is it really seasonal?
    D'Amato G; Murrieta-Aguttes M; D'Amato M; Ansotegui IJ
    World Allergy Organ J; 2023 Jul; 16(7):100799. PubMed ID: 37520612
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Risk of Venous Thromboembolism with Statins: Evidence Gathered via a Network Meta-analysis.
    Birdal O; Saygı M; Doğan R; Tezen O; Karagöz A; Tanboğa İH
    Balkan Med J; 2023 Sep; 40(5):324-332. PubMed ID: 37519020
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Efficacy and safety of antidepressants for smoking cessation: A systematic review and network meta-analysis.
    Deng X; Shang X; Guo K; Zhou L; Wang Y; Wu Y; Liang S; E F; Liu W; Wang Z; Li X; Yang K
    Addict Biol; 2023 Aug; 28(8):e13303. PubMed ID: 37500482
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Fosaprepitant Weekly vs Every 3 Weeks for the Prevention of Concurrent Chemoradiotherapy-Induced Nausea and Vomiting: A Pilot Randomized Clinical Trial.
    Yang Q; Zou X; Xie YL; Lin C; Ouyang YF; Liu YL; Duan CY; You R; Liu YP; Liu RZ; Huang PY; Guo L; Hua YJ; Chen MY
    JAMA Netw Open; 2023 Jul; 6(7):e2326127. PubMed ID: 37498596
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Serotonin Syndrome From Duloxetine Monotherapy: A Case Report.
    Li L; Mi Q
    Cureus; 2023 Jun; 15(6):e40933. PubMed ID: 37496538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.